Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;64(8):815-818.
doi: 10.1007/s00108-023-01547-5. Epub 2023 Jul 11.

[Baricitinib for systemic lupus erythematosus]

[Article in German]
M Aringer  1 , S Nitschmann  2
Affiliations

[Baricitinib for systemic lupus erythematosus]

[Article in German]
M Aringer et al. Inn Med (Heidelb). 2023 Aug.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

References

Literatur

    1. Karonitsch T, Feierl E, Steiner CW et al (2009) Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells. Arthritis Rheum 60:1463–1471 - DOI - PubMed
    1. Illei GG, Shirota Y, Yarboro CH et al (2010) Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study. Arthritis Rheum 62:542–552 - DOI - PubMed - PMC
    1. Aringer M, Stummvoll GH, Steiner G et al (2001) Serum interleukin-15 is elevated in systemic lupus erythematosus. Rheumatology 40:876–881 - DOI - PubMed
    1. Gadina M, Le MT, Schwartz DM et al (2019) Janus kinases to jakinibs: from basic insights to clinical practice. Rheumatology 58(i4):i16
    1. Wallace DJ, Furie RA, Tanaka Y et al (2018) Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet 392:222–231 - DOI - PubMed

LinkOut - more resources